Given that CCRL2 is overexpressed in leukemias with erythroid differentiation and its deletion decreases the survival and clonogenicity of erythroleukemic cells(16), the effect of anti-CCRL2 ADC on healthy erythroid progenitors was assessed. This evidence concerns the gene CCRL2 and leukemia.